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The seroprevalence of Mycoplasma bovis infection in dairy cows in Guangxi Zhuang Autonomous 
Region (GZAR) in subtropical southern China was surveyed between June 2009 and March 2010. A total 
of 455 serum samples of dairy cows were collected from 6 districts in 4 different cities, and examined 
for M. bovis antibodies with the indirect enzyme-linked immunosorbent assay (ELISA) using a 
commercially available kit. The overall seroprevalence of M. bovis infection in dairy cows was 7.69% 
(35/455). Three year-old dairy cows had the highest seroprevalence (15.0%), followed by dairy cows of 4 
year-old (11.1%). Dairy cows with the history of 5 pregnancies had the highest seroprevalence (33.3%). 
However, no statistically significant association was found between M. bovis infection and age or 
number of pregnancies (p > 0.05). All the aborting dairy cows were negative for M. bovis antibodies, 
suggesting that bovine abortion may have no association with M. bovis infection in GZAR. These 
results indicate that M. bovis infection in dairy cows was widespread in GZAR, and integrated strategies 
and measures should be performed to control and prevent M. bovis infection and disease outbreak. 
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Mycoplasma bovis is one of major bovine pathogens and 
is associated with a number of diseases including 
respiratory diseases and severe otitis, and most 
commonly implicated in mastitis and pneumonia 
(Nicholas and Ayling, 2003; Foster et al., 2009; Ball and 
Nicholas, 2010). M. bovis infection is chronic and 
nonresponsive to antimicrobial treatment, and it usually 
co-exists with other bacteria. Therefore, disease 
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great economic loss and can be economically devastating 
to the affected farms, especially in developing countries 
(Butler et al., 2000; Stipkovits et al., 2000; Gagea et al., 
2006; Caswell and Archambault, 2009; Maunsell et al., 
2009; Wiggins et al., 2011). However, despite the 
widespread socioeconomic impact of the pathogen, 
knowledge on the seroprevalence of M. bovis in China is 
scarce and there has been only one epidemiological 
investigation of M. bovis in dairy cows infection in 
Chongqing, China conducted so far, which revealed a 
seroprevalence of 20 to 80% (Ran et al., 2010). 
Dairy cow is one of the most important farm animals for 
milk production in Guangxi Zhuang Autonomous Region 
(GZAR), in subtropical southern  China. The  objective  of  




Table 1. Seroprevalence of M. bovis infection in dairy cows in different cities, in Guangxi Zhuang 
Autonomous Region (GZAR), China. 
 
City Region of city Examined number Positive number Prevalence (%) 
Baise Youjiang 44 4 9.09 
Guilin Qixing 91 8 8.79 
Nanning Xixiangtang 91 3 3.30 
 Yongning 91 9 9.89 
Liuzhou Liunan 47 7 14.89 
 Liubei 91 4 4.40 




Table 2. Seroprevalence of M. bovis infection in dairy cows of different ages in Guangxi 
Zhuang Autonomous Region (GZAR), China. 
 
Age (year) Examined number Positive number Prevalence (%) 
1 8 0 0 
2 25 1 4 
3 20 3 15 
4 36 4 11.11 
5 38 2 5.26 
6 28 1 3.57 
7 20 0 0 
8 18 1 5.56 
>8 18 2 11.11 




this study was to investigate the seroprevalence of M. 
bovis infection in GZAR. The results would provide 
baseline data for the implementation of effective 
strategies for the control of M. bovis infection in dairy 
cows in China. 
 
 
MATERIALS AND METHODS 
 
The study was conducted between June 2009 and March 2010 in 6 
main cow-rearing districts of 4 administrative cities in GZAR. These 
4 cities are the main cow breeding and milk producing areas in 
GZAR. Cows were randomly selected and blood samples were 
collected from tail vein of 455 dairy cows (Table 1). The serum was 
removed by centrifugation at 4,000 ×g for 10 min and stored at -
20°C until testing.  
Serum samples were tested by the indirect enzyme-linked 
immunosorbent assay (ELISA) using a commercially available kit 
(Bovine Mycoplasma antibody ELISA kit, Jiahui BioTech, Ltd, 
Xiamen, China). Positive and negative controls were provided in the 
kit. Optical density of the samples was read with a photometer 
(BIO-RAD, Hercules, California, USA). The testing was performed 
according to the manufacturer’s instructions. Basic biometric data 
on dairy cows including age (records from 211 cows), number of 
pregnancies (from 207 cows) and history of abortions (from 268 





Statistical analysis of M. bovis prevalence in dairy cows of different  
age (in years), with abortion or without abortion, and different 
numbers of pregnancies were performed by chi-square test using 
the SPSS software (Statistical Analysis System, Version 11.5, 
Chicago, Illinois). The differences were considered statistically 





Antibodies to M. bovis were found in 35 out of 455 dairy 
cows yielding the overall seroprevalence of 7.69%. M. 
bovis seroprevalence in dairy cows from different 
geographical locations ranged from 3.3 to 14.89% (Table 
1). 
The highest seroprevalence of 15% (3/20) was found in 
3-year-old dairy cows followed by 11.11% in 4-year-old 
cows (4/36). No seropositive samples were found in 1 
year-old animals and 7 year-old cows (Table 2). No 
relationship between the seroprevalence and the age 
could be revealed. 
The highest prevalence was found in dairy cows with 5 
pregnancies (33.33%), followed by dairy cows having 1 
and 3 pregnancies (6.12%). The M. bovis seroprevalence 
in dairy cows with different numbers of pregnancies 
ranged from 0 to 33.33%, but there were not statistically 
significant differences among different groups (p > 0.05). 
No M. bovis antibodies were found in dairy cows with 0, 6 
and 7 pregnancies (Table 3). 




Table 3. Seroprevalence of M. bovis infection in dairy cows with different numbers of 










0 11 0 0 
1 49 3 6.12 
2 51 3 5.88 
3 49 3 6.12 
4 30 1 3.33 
5 6 2 33.33 
6 10 0 0 
7 1 0 0 




The seroprevalence of M. bovis in non-abortion dairy 
cows was 8.33% (22/264). There were 4 cows with 
abortion, including 2 dairy cows that aborted 3 and 2 






M. bovis is a major cause of calf pneumonia, mastitis and 
arthritis, and a comprehensive understanding of M. bovis 
seroprevalence in dairy cows is essential for the control 
and prevention of M. bovis infection. M. bovis infection 
have been reported globally, with prevalence of 13 to 
23% in Ireland, 25 to 50% in UK, 70% in USA, and 60 to 
100% in France (Byrne et al., 2001; Nicholas et al., 2003; 
Arcangioli et al., 2008). It is estimated that up to 1.9 
million cows become infected annually in UK, with 
157,000 calves lost due to pneumonia and related 
diseases (Nicholas and Ayling, 2003). However, there 
was only one survey of M. bovis seroprevalence in 
Chongqing, China. 
This study indicates that the overall M. bovis 
seroprevalence in GZAR was lower than that in other 
countries (Byrne et al., 2001; Nicholas and Ayling, 2003; 
Arcangioli et al., 2008) and in Chongqing, China (Ran et 
al., 2010), but close to the lowest level in Ireland (Byrne 
et al., 2001). However, it was also found that there were 
particular groups which had high M. bovis 
seroprevalence, such as those of 3 and 4-year-old as 
well as those with a history of 1, 3 and 5 pregnancies. 
Cows of 3 to 4 years old were the main producers of milk. 
Thus, high M. bovis seroprevalence in these ages will  
increase the risk of milk contamination with M. bovis. In 
addition, cows of 3 or 4 years old and those with a history 
of a few pregnancies were the main part of a herd, 
therefore, carrier dairy cows are the most likely source for 
the infection for calves in M. bovis-positive dairy herds. 
The seroprevalence of M. bovis in GZAR in dairy cows 
without abortion was 8.33%, and no M. bovis antibodies 
were found in aborting dairy cows, including those with 
high frequency of abortions (2 and 3 times for each). This 
suggests that no association between bovine abortion 
and M. bovis infection exists in GZAR and abortions 
might be caused by factors other than M. bovis infection. 
Results of this study indicate that infection of dairy 
cows with M. bovis was widespread in GZAR. It was 
reported that healthy dairy cows can be infected with M. 
bovis by clinically healthy calves or young cows shedding 
the Mycoplasma, and the pathogen is then very difficult to 
be eradicated once introduced into a herd, and there are 
no commercial vaccines for M. bovis at present (Nicholas 
and Ayling, 2003; Nicholas et al., 2009). Therefore, 
integrated strategies and measures should be executed 
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